Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Very well said my friend! Exactly my thoughts! Todays pps equals 0,055 pre split, never forget that! Has traded above 0,30 (6 bagger) only on rumors before...
Klins: i hope to see Lummy news by Friday. I have a feeling the deal depants on the money ARGS still need. I will hold my shares even if we get no news befote Friday. I'm just saying, noone knows what is gonna happen and if it's good, i want to be in, if it's bad i want to be out, but whaterver happens i will hold my shares. It would be crazy to see ARGS go to the otc after all the hard work they put in it, trying to stay on the Nasdaq. If they fail, they could have better directly moved from the global market to te otc iso the capital market. So I say... Stay long, but then again, it's just my opinion. Glta
Havn't got a clue. With the volume of the last days, i really think they will get to the $2.5milSE. If ARGS PR that, i don't want to be out. But if they did not get to 2.5.... I hope i'm not in. For sure waiting till Friday to see. Fingers crossed.
d:
What are you looking for w/r/t trading trends leading up to 4/24? I see no previous patterns in this stock to use as a guideline.
If you wait till 24th you will be too late, if news of compliance hit the wire, ARGS will explode. If you buy now, it can be too early, if they can’t get to compliance ARGS will move to the otcbb and the rest you know. Imo they stil needed 5 to 6 mil dollar and I think they are not far away from that anymore. + Lummy deal still has to come. I’m betting ARGS will get to the $2.5mil SE.
* * $ARGS Video Chart 04-16-18 * *
Link to Video - click here to watch the technical chart video
Do u think with the recent action the last few days or week that they’ll be good? Something is pushing this as of late but I don’t see any recent news.... part of me says to get in now, part of me says wait til the 24th?
They need $2.5mil shareholders equity by the 24th of April. No share price involved
What price does this need to get to for them to be fine?
Breakout mode! Glad I've added A LOT under 1$ :)
I cannot remember....
Trompete, i think you might be on to something. Equity at ARGS is gone from the noncompliant companies listing center. Can anyone confirm that ‘equity’ was on the list last week?
The other requirements are met in the mean while, so no problem.
https://listingcenter.nasdaq.com/assets/continuedguide.pdf
If you take ABIL in the list, you will see ‘equity’ at ARGS ‘equity’ is gone???
https://listingcenter.nasdaq.com/NonCompliantList.aspx
But acc to the list there are 2 additional compliance issues right?
Ok, critical then...
Nope, not in that list... but it is in the last Q
‘In January 2018, the Company implemented a one-for-twenty reverse stock split, and subsequently regained compliance with the Nasdaq $1.00 minimum bid price requirement. The Company was also granted an extension until April 24, 2018 to regain compliance with the $2.5 million minimum shareholders’ equity requirement for continued listing on the Nasdaq Capital Market.’
I don't see this violation here: https://listingcenter.nasdaq.com/NonCompliantCompanyList.aspx
$2.5mil stockholder equity rule. ARGS has till the 24th of April to be in compliance. Otherwise they will have to move to the otc. Even if trial results are good, a move to the otc will first cause a big hit down imo. But still, I think ARGS willget to that 2.5mil SE and that will cause a big run north.
Yes, but the results on the AGS003 will come too late for the compliance. Results will not be out before the 24th of April.
I don't know if they get compliance or not, hopefully they'll get it. I want sort of clear and strong messages re science, if they provide this then compliance is nothing, investors will get it done. Without the science it is pump and dump anyway
So you say they will get to compliance? Cause they really only have till the 24th. Why would they do all this effort to get in compliance if the trial is not good? Compliance means, get to 2.5mil, but also prove they can hold this 2.5mil for a longer periode. It is still a big guess. But it seems the sky is clearing up for ARGS. Compliance will tell more then just being in compliance imo. If you know what I mean.
I'm not worried about lummy or compliance. If the science is good then the rest is only a technical thing. Question is IF the science is good...
They need to give news. Lummy deal has to come this week or before the 24th...? $2.5mil SE before the 24th of April. If ARGS PR that they are in compliance with the 2.5mil SE this could start to make a real big run. Nothing left to hold the stock down then. Money till end 2018 in compliance with Nasdaq Capital market and AGS 003 ph 3 news coming and AGS 004 ph news comig. Really it looks to me they will get to the 2.5mil (why is Lummy waiting that long??? To see how much money is still needed???). I say ARGS is ready to make a big run north imo. Glta and hagwe. D
If no good info follows next week or till end of the month, we're screwed
As far as my personal own estimates and in my opinion, since March 16th there has been an acceleration of share sales due to the ATM. In my estimates total volume is around 5.4M and I do estimate around 10% might be short sales. If my math and my hypothesis is correct, they might have raised around 4.2M at an average selling price of 0.9 pps, in 18 business days. With a little below half of this timeframe left to raise the additional needed money to reach 2.5M s.e. (around 2 to 2.5M left to raise in my estimates before deadline), and once volume has settled down a bit after the shake-up, if volume in the next days will be low, there might be some high volatility on the stock. Just my own personal opinion.
It's ok to be sceptical here - but otc delisting is waaaay more away than 10$ f.e.
Yes, but 205,000,000 is something much different than 2,000,000,000. I really think the will try to avoid going to otc. An important week is coming.
I would think the OS is higher than that figure based on the recent 10-k.
Everyone does understand the difference between stockholders of record and beneficial owners, right?
According to the latest information from the State of Delaware, Argos's AS is 205,000,000 shares.
Anyone can confirm that as, cause I can’t find the as anywhere... tnx
www.nasdaq.com/symbol/args/institutional-holdings - 8M outstanding.
ARGS is in nasdaq, so nasdaq is the place where to look up for info.
I'm not happy seeing this from your link.
Suggests to me they intend on taking their ATM to the OTC.......
O/S Just 8,OOO,OOO
https://www.otcmarkets.com/stock/ARGS/security
Gonna be very helpful soon... :)
https://nakedshortreport.com/company/ARGS
Added another big chunk @0,99 today. Now I can really feel it :)
* * $ARGS Video Chart 04-11-18 * *
Link to Video - click here to watch the technical chart video
after-hour inch up
That's why I bought more yesterday.
Lots of filings to read through... Nearly nothing has happened today regarding the 3 or 6 month chart!
one twitter person mentioned about fda news or something.
I´m reading the filings and acting with patience still adding lots of shares bc I know what´s possible...
are you waiting for some kind of news?
Expected big walls on ask building again. Good sign - very nice days ahead in ARGS land! Imo
Thx bro! Side by side here!
Still not a day to freakout, but a good step into the right direction...
Interim report has lead to the constant decline. Note the endpoint for Inlyta- extending disease free survival.
See the tail for ARGS phase 2 trial.
Indeed.... What is the reason to value this company at $10mil??? Any catalyst for that? Right on Klinsmann.
What has been the catalyst for 0,75?!?
What's the catalyst today? Inlyta news?
Followers
|
55
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1990
|
Created
|
06/28/14
|
Type
|
Free
|
Moderators |
- Feb '17 DMC Recommends Discontinuation of AGS-003 ADAPT Trial
- March '17 Communicated BK risk
- April '18 AGS-003 ADAPT Trial Perspective to Continue Trial
- May '17 FDA Agrees on AGS-003 ADAPT Continuation and will Review Protocol Amendment
- June '17 $5M funding round - BK risk removed, company continues
- July '17 AGS-004 Open-Label Ph1 HIV Trial Reaches PE, 6 pt, 2-fold increase
- Sep '17 AGS-004 Phase 2 HIV eradication trial : Dosing First Patient
- Sep '17 AGS-003 ADAPT Trial Interim Data Discussion @ ESMO
- Nov '17 Lummy made a $1.5M milestone payment
- Dec '17 CC Transcript
- Jan '18 Lummy's $1.5M 0.375M shares @ $4/sh equity investment, to be closed & converted on 2018-03-07
- Jan '18 RS 1:20
- Feb '18 424B5 of $200M Shelf 333-215480: $15M Equity Sales via Cowen, ATM
- Feb '18 Option to license PD1 Checkpoint Inhibitors for other/more drug variants (?)
- Feb '18 Received a patent for AGS-004 production, their HIV drug
- Early 2018 AGS-004 Pilot Trial 12 patients, primary completion March 2018. Positive data from 6 patients published.Current EV 2018-03-16 8-K
Goes on OTCQB on 4/23 '18
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |